O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
Clinical trial NCT00436436 · TERMINATED
Trial details
- NCT number
- NCT00436436
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-13
- Primary completion
- 2010-03-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.